Lorazepam vs Midazolam

## Overview

Lorazepam and midazolam are both widely used in hospital settings but for different purposes. Midazolam is water-soluble at low pH and highly lipophilic at physiological pH, enabling rapid IM absorption and IV onset, making it the primary BZD for procedural sedation and anesthesia induction. Lorazepam is preferred for prolonged sedation in ICU and status epilepticus.

## Mechanism of Action

Both potentiate GABA-A receptor-mediated Cl- influx. Midazolam's imidazoline ring opens at acid pH (water-soluble for IM injection) and closes at physiological pH (lipophilic for CNS penetration) — a unique pH-dependent chemical property.

## Pharmacokinetics

Midazolam: half-life 1.5–2.5 h, CYP3A4 metabolism, no significant active metabolites in adults (1-OH-midazolam has some activity), excellent IM absorption (bioavailability ~90% IM). Lorazepam: half-life 10–20 h, glucuronidation (no CYP), no active metabolites.

## Clinical Applications

Procedural sedation: midazolam (rapid IV/IM onset, short duration, amnestic effect). Anesthesia premedication: midazolam IV/IM. Status epilepticus: IV lorazepam preferred; IM midazolam non-inferior when IV access unavailable. ICU sedation: midazolam infusion (although propofol/dexmedetomidine often preferred now). Alcohol withdrawal: not primary choice (lorazepam preferred).

## Amnesia

Midazolam produces profound anterograde amnesia at sedating doses, making it particularly valued for unpleasant procedures. Lorazepam also produces amnesia but with slower onset.

## Key Takeaways

- Midazolam: rapid onset, short duration, profound amnesia, preferred for procedural sedation
- Lorazepam: longer duration, no active metabolites, preferred for status epilepticus IV
- Midazolam IM: first-line for prehospital/IM status epilepticus (faster than IV diazepam IM)